Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Neoadjuvant chemotherapy response in androgen receptor-positive triple-negative breast cancer: potential predictive biomarkers and genetic alterations

Fig. 3

TNBC subtype and response to neoadjuvant therapy. A pCR rates in FOXC1-positive and FOXC1-negative TNBC patients. B AR expression levels in FOXC1-positive and FOXC1-negative/AR-positive TNBC patients. C pCR rates in FOXC1-positive and FOXC1-negative patients with and without AR expression. D Representative images of AR and FOXC1 staining in AR-positive TNBC patients

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us